Breast-conserving therapy for breast cancer: Cosmetic results and options for delayed reconstruction.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2017 Vol.70(10) p. 1336-1344

Negenborn VL, Volders JH, Krekel NMA, Haloua MH, Bouman MB, Buncamper ME, Niessen FB, Winters HAH, Terwee CB, Meijer S, van den Tol MP

관련 도메인

Abstract

[OBJECTIVES] Optimisation of the cosmetic outcome after breast-conserving therapy (BCT) is important. We aimed to determine the cosmetic outcome following BCT and factors influencing this cosmesis and identify the most favourable options for delayed breast reconstruction.

[MATERIALS AND METHODS] Four reconstructive surgeons evaluated the cosmetic outcome of 109 patients after BCT. Additionally, the surgeons indicated which patients were amenable for delayed reconstruction and the preferred type of reconstruction. The inter- and intra-observer agreement of the surgeons was rated.

[RESULTS] The mean overall cosmetic outcome was rated as fair (2.7/4.0, SD 0.9, 1.0-4.0). Risk factors for a poor cosmesis were larger breast size (OR 3.81, p = 0.040), larger tumour (OR 1.63, p = 0.028) and axillary lymph node dissection (ALND) (OR 3.09, p = 0.013). Reconstruction of the ipsilateral side was recommended in 55.6% and 94.5% and contralateral reconstruction in 16.7% and 73.3% of patients with good and poor cosmesis, respectively. Flap reconstruction and lipofilling were most commonly reported for the ipsilateral, and breast reduction for the contralateral breast, with reasonable improvement expected (2.2/4.0, SD 0.5, 1.08-3.3). The inter- (0.5-0.7) and intra-observer (0.63-0.79) agreement of the cosmesis was moderate to good, however, poor regarding the recommended reconstruction techniques (mainly < 0.50).

[CONCLUSION] Cosmetic outcome after BCT is influenced by breast and tumour size and ALND. Although several reconstructive options are available, the optimal method for revision surgery has not yet been determined. Future studies are necessary to obtain evidence-based guidelines for reconstructive surgery after BCT.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 8
시술 breast reduction 유방성형술 dict 1
시술 flap 피판재건술 dict 1
해부 lipofilling scispacy 1
합병증 ipsilateral scispacy 1
약물 [OBJECTIVES] scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 tumour C0027651
Neoplasms
scispacy 1
질환 BCT → breast-conserving therapy scispacy 1
기타 patients scispacy 1
기타 axillary lymph node scispacy 1

MeSH Terms

Adult; Axilla; Breast Neoplasms; Esthetics; Female; Humans; Lymph Node Excision; Lymph Nodes; Mammaplasty; Mastectomy, Segmental; Middle Aged; Netherlands; Patient Outcome Assessment; Patient Preference; Patient Selection; Postoperative Complications; Professional Practice; Quality Improvement; Time-to-Treatment; Tumor Burden

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문